NCT02761616已完成不适用
A Study to Determine Biopsy Rate in Participants With a First Relapse of Breast Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 76
- 试验地点
- 4
- 主要终点
- Percentage of biopsied participants with metastatic relapse
研究概览
简要总结
This is a retrospective, and observational cohort study to determine the proportion of breast cancer first relapses, that are biopsied. The duration of the study will be approximately 24 months.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Participants with histologically confirmed breast cancer treated for early breast cancer (eBC) with first metastatic relapse disease in the period from January 1, 2014 and December 31, 2015
排除标准
- •Not Applicable
结局指标
主要结局
Percentage of biopsied participants with metastatic relapse
时间窗: Approximately up to 24 months
次要结局
- Percentage of biopsied participants at first relapse mBC with same and different molecular profiles between primary tumor and metastasis for each molecular profile(Approximately up to 24 months)
- Percentage of non-biopsied participants at first relapse according to different reasons for not performing a biopsy of the metastasis(Approximately up to 24 months)
- Percentage of biopsied participants at first relapse mBC according to each biopsy method(Approximately up to 24 months)
- Percentage of biopsied and non- biopsied participants at first relapse mBC for each systemic treatment scheme in the adjuvant and in the metastatic setting(Approximately up to 24 months)
- Percentage of biopsied and non-biopsied participants at first relapse metastatic breast cancer (mBC) for each metastatic site(Approximately up to 24 months)
- Percentage of biopsied participants at first relapse mBC for each molecular profile of biopsied metastases(Approximately up to 24 months)
- Percentage of biopsied and non- biopsied participants at first relapse mBC for each molecular profile of primary tumor(Approximately up to 24 months)
- Time to relapse(Approximately up to 24 months)
- Percentage of participants with type of first line therapy selected for metastatic disease(Approximately up to 24 months)
- Percentage of participants influenced with biopsy in mBC(Approximately up to 24 months)
研究者
研究点 (4)
Loading locations...
相似试验
已完成
不适用
A Retrospective Non-interventional Study of Breast Cancer Patients Diagnosed With HR+/HER2- Locally Advanced or Metastatic Breast Cancer Treated With Palbociclib in DenmarkBreast CancerNCT05452798Pfizer1,054
已完成
不适用
A Study to Evaluate the Accuracy of a Breast Cancer Locator (BCL) in Patients With Palpable CancersBreast CancerNCT02550210Dartmouth-Hitchcock Medical Center23
进行中（未招募）
不适用
Breast Cancer Patient Engagement With Patient Reported Outcome Measure SurveyBreast CancerPatient Reported OutcomesNCT03995082University of Colorado, Denver925
已完成
不适用
Morbidity After Diagnosis and Treatment of Breast Cancer PatientsShoulderLymphedemaFatigueBreast CancerNCT00027118National Institutes of Health Clinical Center (CC)326
已完成
1 期
An Exploratory Tumor Biopsy-driven Study to Understand the Relationship Between Biomarkers and Clinical Response in Melanoma Patients Receiving REGN2810 (Anti-PD-1)MelanomaNCT03002376Regeneron Pharmaceuticals47